Mechanisms of neuroprotective drug actions
Krieglstein, J.
Clinical Neuroscience 4(4): 184-193
1997
ISSN/ISBN: 1065-6766 PMID: 9186040 Document Number: 472186
Document emailed within 1 workday
Related Documents
Zalewska-Kaszubska, J. 2002: Neuroprotective mechanisms of adenosine action on CNS neurons Neurologia i Neurochirurgia Polska 36(2): 329-336Zhu, Y.; Dang, S.; Hua, Z. 2010: Advanced achievements about neuroprotective mechanisms of paeoniflorin Zhongguo Zhong Yao Za Zhi 35(11): 1490-1493
Gromova, O.A.; Torshin, I.I.; Gogoleva, I.V. 2014: Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(3 Part 2): 43-50
Gerlach, M.; Desser, H.; Youdim, M.B.; Riederer, P. 1996: New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline Journal of Neural Transmission. Supplementum 48: 7-21
McCulloch, J. 1996: Neuroprotective drug development in stroke: blood pressure and its impact Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 14(5): S131-S138
Appel, J.B.; Cunningham, K.A. 1986: The use of drug discrimination procedures to characterize hallucinogenic drug actions Psychopharmacology Bulletin 22(3): 959-967
Rothwell, N.J. 1990: Mechanisms of the pyrogenic actions of cytokines European Cytokine Network 1(4): 211-213
Kuroki, T.; Kato, R. 1986: On the mechanisms of actions of tumor promoters Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 2): 754-757
Adcock, I.M.; Ito, K. 2000: Molecular mechanisms of corticosteroid actions Monaldi Archives for Chest Disease 55(3): 256-266
Burks, T.F. 1976: Antiadrenergic actions of metiamide in cat thermoregulatory mechanisms Proceedings of the Western Pharmacology Society 19: 75-78
Kosano, H. 2008: Synthetic estrogens: some new pharmacological actions and mechanisms Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 104-110
Kushiku, K.; Ohba, M.; Mikagi, T.; Nuki, S.; Araki, Y.; Furukawa, T. 1989: Cardiovascular actions of buflomedil and possible mechanisms involved Arzneimittel-Forschung 39(6): 670-677
Nowak, G.; Szewczyk, B. 2002: Mechanisms contributing to antidepressant zinc actions Polish Journal of Pharmacology 54(6): 587-592
Fischer, H.D.; Schmidt, J.; Wustmann, C. 1984: On some mechanisms of antihypoxic actions of nootropic drugs Biomedica Biochimica Acta 43(4): 541-543
Satou, M. 2013: Molecular mechanisms involved in the diverse actions of ghrelin Seikagaku. Journal of Japanese Biochemical Society 85(7): 557-561
Bagdy, G. 1996: Studies on the sites and mechanisms of 5-HT1A receptor-mediated in vivo actions Acta Physiologica Hungarica 84(4): 399-401
Cowley, A.W. 1984: Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy Hypertension 6(2 Part 1): 137-139
Pilipchuk, N.S.; Kliachkin, L.M.; Protsiuk, R.G. 1989: Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 21-24
Nezhentsev, M.V.; Aleksandrov, S.I. 1994: The current concepts of the humoral mechanisms of the analgetic and antipyretic actions of acupuncture (a review of the literature) Likars'ka Sprava 1994(3-4): 39-42
Hill, R.T. 1975: Neurochemical mechanisms in rat behavioral models of the euphorigenic and antihyperkinetic actions of psychomotor stimulant drugs Psychopharmacology Bulletin 11(3): 37-38